editorial | Q871232 |
scholarly article | Q13442814 |
P2093 | author name string | Marco G Patti | |
Irving Waxman | |||
P2860 | cites work | Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 |
Gastroesophageal reflux disease: From pathophysiology to treatment | Q34063683 | ||
Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery? | Q34063689 | ||
Pathophysiology and treatment of Barrett's esophagus | Q34063695 | ||
Effect of medical and surgical treatment of Barrett's metaplasia | Q34063700 | ||
Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? | Q34063704 | ||
Neoadjuvant treatment of esophageal cancer | Q34063710 | ||
Minimally invasive esophagectomy | Q34063715 | ||
Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology | Q34365819 | ||
A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer | Q34593949 | ||
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry | Q37114959 | ||
Minimally invasive esophagectomy for cancer | Q37308705 | ||
Advances in diagnostic testing for gastroesophageal reflux disease | Q37779054 | ||
Endoscopic treatment of Barrett's esophagus: From metaplasia to intramucosal carcinoma | Q37779056 | ||
Transhiatal versus transthoracic esophagectomy for esophageal cancer | Q37779057 | ||
Anatomy and physiology of the gastroesophageal junction | Q41601233 | ||
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial | Q45172897 | ||
Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. | Q45932787 | ||
Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: A follow-up analysis of another decade | Q46930609 | ||
The burden of selected digestive diseases in the United States | Q50113541 | ||
Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? | Q73742683 | ||
Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer? | Q79847207 | ||
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience | Q84427324 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gastroesophageal reflux disease | Q223591 |
P304 | page(s) | 3743-3744 | |
P577 | publication date | 2010-08-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Gastroesophageal reflux disease: From heartburn to cancer | |
P478 | volume | 16 |
Search more.